Biotech CEO/CBO Kris Elverum has worked in large pharma and small biotech firms. He currently acts as a consultant and advisor to both biotech and venture capital companies. Kris joins Maria Whitman on the podcast to share his perspective on precision medicine and the opportunities he sees ahead.
Highlights from the episode:
- Challenges Kris faced transitioning from broader therapeutics to precision medicine
- How biopharma companies big and small can succeed in this sector
- Advice for company leaders who want to pursue precision medicine
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
